The Therapeutic Goods Administration (TGA) has approved the new Therapeutic Goods (Permissible Ingredients) Determination No. 1 of 2017 under Section 26BB of the Therapeutic Goods Act 1989. TGA anticipates that the updated Determination will be published and available on the Federal Register of Legislation (FRL) after 30 January 2017. CMA has also requested that TGA publish a forward plan for quarterly updates to the Ingredients Determination for 2017 to assist industry with business planning.


Click here to read more